
Gene Report
Approved Symbol | SRD5A2 |
---|---|
Approved Name | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
Location | 2p23.1 |
Position | chr2:31522480-31581067, -1 |
External Links |
HGNC: 11285 Entrez Gene: 6716 Ensembl: ENSG00000277893 UCSC: uc032nip.1 |
No. of Association Results | 11 (Positive: 11; Negative: 0; trend: 0) |
Annotation Type | Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
Reference | Phenotype | Marker | Gene's Category |
---|---|---|---|
Gillespie, Charles F.,2013 | Avoidance/Numbing symptoms | rs523349 | Significant |
Gillespie, Charles F.,2013 | Hyperarousal symptoms | rs523349 | Significant |
Gillespie, Charles F.,2013 | Intrusive/Reexperiencing symptoms | rs523349 | Significant |
Gillespie, Charles F.,2013 | Proxy-diagnosis of PTSD | rs523349 | Significant |
Gillespie, C. F.,2013 | PSS avoidance/numbing subscale | rs523349 | Significant |
Gillespie, C. F.,2013 | PSS hyperarousal subscale | rs523349 | Significant |
Gillespie, C. F.,2013 | PSS intrusive/reexperiencing subscale | rs523349 | Significant |
Nievergelt, C. M.,2015 | PTSD | rs77929608 | Significant |
Gillespie, C. F.,2013 | PTSD diagnosis | rs523349 | Significant |
Gillespie, C. F.,2013 | Total PSS score | rs523349 | Significant |
Gillespie, Charles F.,2013 | Total PTSD symptoms | rs523349 | Significant |
Reference | Phenotype | Environment | Marker | Gene's Category |
---|---|---|---|---|
Gillespie, Charles F.,2013 | Proxy-diagnosis of PTSD | Sex | rs523349 ; rs77929608 | Significant |
ID | Name | No. of Genes in PTSDgene |
---|---|---|
hsa00120 | Bile acid biosynthesis | 1 |
hsa00150 | Androgen and estrogen metabolism | 2 |
hsa05215 | Prostate cancer | 3 |
Copyright: Key Lab of Mental Health, Institute of Psychology, Chinese Academy of Sciences Feedback
Last update: April 1, 2018